| Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases A Bolhassani, S Javanzad, T Saleh, M Hashemi, MR Aghasadeghi, ... Human vaccines & immunotherapeutics 10 (2), 321-332, 2014 | 355 | 2014 |
| Synthesis, biological evaluation, and molecular modeling studies of new 1,3,4-oxadiazole- and 1,3,4-thiadiazole-substituted 4-oxo-4H-pyrido[1,2-a]pyrimidines as … Z Hajimahdi, A Zarghi, R Zabihollahi, MR Aghasadeghi Medicinal Chemistry Research 22 (5), 2467-2475, 2013 | 98 | 2013 |
| HIV-1 Vpr protein enhances proteasomal degradation of MCM10 DNA replication factor through the Cul4-DDB1 [VprBP] E3 ubiquitin ligase to induce G2/M cell cycle arrest B Romani, NS Baygloo, MR Aghasadeghi, E Allahbakhshi Journal of Biological Chemistry 290 (28), 17380-17389, 2015 | 76 | 2015 |
| Smart bomb AS 1411 aptamer‐functionalized/PAMAM dendrimer nanocarriers for targeted drug delivery in the treatment of gastric cancer A Barzegar Behrooz, F Nabavizadeh, J Adiban, M Shafiee Ardestani, ... Clinical and Experimental Pharmacology and Physiology 44 (1), 41-51, 2017 | 74 | 2017 |
| The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients P Rahimi, R Tarharoudi, A Rahimpour, J Mosayebi Amroabadi, I Ahmadi, ... Virology journal 18 (1), 221, 2021 | 65 | 2021 |
| Tumor cell-based vaccine: an effective strategy for eradication of cancer cells SA Sadeghi Najafabadi, A Bolhassani, MR Aghasadeghi Immunotherapy 14 (8), 639-654, 2022 | 63 | 2022 |
| HCV core protein immunization with Montanide/CpG elicits strong Th1/Th2 and long-lived CTL responses F Roohvand, MR Aghasadeghi, SM Sadat, A Budkowska, AR Khabiri Biochemical and biophysical research communications 354 (3), 641-649, 2007 | 61 | 2007 |
| MPG-based nanoparticle: An efficient delivery system for enhancing the potency of DNA vaccine expressing HPV16E7 T Saleh, A Bolhassani, SA Shojaosadati, MR Aghasadeghi Vaccine 33 (28), 3164-3170, 2015 | 58 | 2015 |
| Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio‐behavioural surveillance survey in 2015 G Moradi, MM Gouya, F Azimizan Zavareh, A Mohamadi Bolbanabad, ... Tropical Medicine & International Health 23 (6), 641-649, 2018 | 56 | 2018 |
| Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis N Khairkhah, MR Aghasadeghi, A Namvar, A Bolhassani Plos one 15 (10), e0240577, 2020 | 55 | 2020 |
| Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011 F Jahanbakhsh, J Hattori, M Matsuda, S Ibe, SHR Monavari, ... PloS one 8 (4), e61864, 2013 | 53 | 2013 |
| HIV-1 Vpr protein induces proteasomal degradation of chromatin-associated class I HDACs to overcome latent infection of macrophages B Romani, NS Baygloo, M Hamidi-Fard, MR Aghasadeghi, ... Journal of Biological Chemistry 291 (6), 2696-2711, 2016 | 52 | 2016 |
| HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin B Romani, R Kamali Jamil, M Hamidi-Fard, P Rahimi, SB Momen, ... Scientific reports 6 (1), 31924, 2016 | 50 | 2016 |
| Vulnerability of homeless people in Tehran, Iran, to HIV, tuberculosis and viral hepatitis F Bagheri Amiri, MM Gouya, M Saifi, M Rohani, P Tabarsi, A Sedaghat, ... PLoS One 9 (6), e98742, 2014 | 50 | 2014 |
| Gd3+-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent M Amanlou, SD Siadat, SES Ebrahimi, A Alavi, MR Aghasadeghi, ... International Journal of Nanomedicine, 747-763, 2011 | 48 | 2011 |
| Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients G Bahramali, M Sadeghizadeh, S Amini-Bavil-Olyaee, SM Alavian, ... World Journal of Gastroenterology: WJG 14 (35), 5448, 2008 | 48 | 2008 |
| Nanosilver based anionic linear globular dendrimer with a special significant antiretroviral activity MS Ardestani, AS Fordoei, A Abdoli, R Ahangari Cohan, G Bahramali, ... Journal of Materials Science: Materials in Medicine 26 (5), 179, 2015 | 45 | 2015 |
| Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency N Rezaei, SD Siadat, A Aghamohammadi, M Moin, Z Pourpak, ... Clinical and Vaccine Immunology 17 (4), 524-528, 2010 | 45 | 2010 |
| Application of outer membrane vesicle of Neisseria meningitidis serogroup B as a new adjuvant to induce strongly Th1-oriented responses against HIV-1 M Reza Aghasadeghi, A Sharifat Salmani, S Mehdi Sadat, F Javadi, ... Current HIV research 9 (8), 630-635, 2011 | 44 | 2011 |
| Development of single-cycle replicable human immunodeficiency virus 1 mutants R Zabihollahi, S Sadat, R Vahabpour, M Aghasadegh, A Memarnejadian, ... Acta virologica, 2011 | 42 | 2011 |
